Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 10/20 | 0.51 |
| ▸ | OPRM1 | P35372 | 7/20 | 0.51 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.51 |
| ▸ | FNTA | P49354 | 3/20 | 0.46 |
| ▸ | FNTB | P49356 | 3/20 | 0.46 |
| ▸ | PGGT1B | P53609 | 3/20 | 0.46 |
| ▸ | C3AR1 | Q16581 | 1/20 | 0.44 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.44 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.44 |
| ▸ | QRFPR | Q96P65 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29575686 | 0.98 | OPRD1 (0.49) | OPRD1OPRM1OPRK1FNTAFNTB | |
| SCHEMBL30626300 | 0.93 | OPRD1 (0.53) | OPRD1OPRM1OPRK1QRFPR | |
| SCHEMBL29630522 | 0.93 | OPRD1 (0.49) | OPRD1OPRM1OPRK1 | |
| SCHEMBL30692724 | 0.92 | OPRD1 (0.53) | OPRD1OPRM1OPRK1 | |
| SCHEMBL29630726 | 0.92 | OPRD1 (0.51) | OPRD1OPRM1OPRK1 | |
| SCHEMBL29569045 | 0.91 | OPRM1 (0.47) | OPRD1OPRM1OPRK1ERAP2LNPEP | |
| SCHEMBL29630648 | 0.91 | OPRD1 (0.47) | OPRD1OPRM1OPRK1FNTAFNTB | |
| SCHEMBL29568713 | 0.91 | ERAP2 (0.51) | OPRD1OPRM1OPRK1ERAP2LNPEP | |
| SCHEMBL29569091 | 0.91 | ERAP2 (0.51) | OPRD1OPRM1OPRK1ERAP2LNPEP | |
| SCHEMBL29568898 | 0.90 | OPRL1 (0.50) | OPRD1OPRM1OPRK1ERAP2LNPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807899-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | Biocrucible Limited | 2023-11-07 | — | — | US | disclosed |
| US-20220145378-A1 | BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS | Biocrucible Limited (GB) | 2022-05-12 | — | — | US | disclosed |